The following article, FDA Authorizes Third Dose of COVID-19 Boosters for Emergency Use, was first published on Flag And Cross.
With only about 70% of America fully willing to be vaccinated against COVID-19, the Biden administration has been hard at work trying to convince the rest of the nation to get on board. Otherwise, there are fears among some health experts that reaching herd immunity could get difficult.
But those out there who remain unvaccinated have almost exclusively made that choice of their own accord, and aren’t likely to be inoculated anytime soon…especially if the entire vaccination process gets any more involved.
Unfortunately, it appears that this is the way things are trending, at least for some of the at-risk individuals among us.
The U.S. Food and Drug Administration expanded emergency use of Pfizer-BioNTech and Moderna’s COVID-19 vaccines to authorize a booster shot for certain immunocompromised patients.
HIV and cancer patients, organ transplant recipients and those taking immunosuppressant drugs comprise about 2.7% of the U.S. adult population.
Growing evidence had suggested select immunocompromised patients mount a diminished protective immune response, even after two doses of vaccine.
Research published in the New England Journal of Medicine on Wednesday among 120 organ transplant recipients who received a third dose of Moderna’s vaccine indicated a substantial boost in neutralizing antibodies and T-cell counts, compared to a group receiving saline placebo.
The news comes as a number of studies have examined vaccine efficacy against the emerging delta variant, with mixed results.
Continue reading: FDA Authorizes Third Dose of COVID-19 Boosters for Emergency Use ...